The Danish Cardiovascular Screening Trial (DANCAVAS)

Not Applicable

• Conditions: Cardiovascular disease; Circulatory System

• Registration Number: ISRCTN12157806
• Lead Sponsor: The Region of Southern Denmark

Brief Summary

2015 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/26637993 protocol 2020 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31679079 results (added 06/11/2019) 2020 Results article in https://www.ncbi.nlm.nih.gov/pubmed/32158272 results (added 12/03/2020) 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/30919411/ baseline results (added 12/08/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34376488/ results (added 12/08/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36027560/ 5-year follow-up (added 30/08/2022) 2022 Results article in https://www.nejm.org/doi/10.1056/NEJMoa2208681 5 year outcomes (added 17/01/2023) 2024 Other publications in https://pubmed.ncbi.nlm.nih.gov/38739644/ Post hoc analyses (added 14/05/2024)

Detailed Description

Not available

Study Timeline

• Study Start: 2015-03-21
• Last Update Posted: 27 May 2024
• Study Completion: 2026-01-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: Male
• Target Recruitment: 47322

Inclusion Criteria

Danish men aged 65-74 years old living in the Island of Fyn, and the communities of Vejle and Silkeborg in Denmark.

Exclusion Criteria

1. Women
2. Men younger than 65 years

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
All cause mortality

Secondary Outcome Measures

Name	Time	Method
1. Costs and cost effectiveness after 3, 5 and 10 years to assess possible health and/or societal benefits of the screening.<br>2. Nationwide registry based information on health care consumption including contacts to GP and use of drugs, as well as hospital submissions.